Page last updated: 2024-11-01

norfloxacin and Amebiasis, Intestinal

norfloxacin has been researched along with Amebiasis, Intestinal in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oyofo, BA1
Peruski, LF1
Ismail, TF1
el-Etr, SH1
Churilla, AM1
Wasfy, MO1
Petruccelli, BP1
Gabriel, ME1
Yang, JG1
Wu, FY1
Shen, XJ1

Other Studies

2 other studies available for norfloxacin and Amebiasis, Intestinal

ArticleYear
Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.
    Military medicine, 1997, Volume: 162, Issue:6

    Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Blas

1997
[Quinolones in the treatment of acute amebic dysentery].
    Zhonghua nei ke za zhi, 1991, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Dysentery, Amebic; Female; Huma

1991